BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
Titel:
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib
Auteur:
Bonfiglio, Silvia Sutton, Lesley-Ann Ljungström, Viktor Capasso, Antonella Pandzic, Tatjana Weström, Simone Foroughi-Asl, Hassan Skaftason, Aron Gellerbring, Anna Lyander, Anna Gandini, Francesca Gaidano, Gianluca Trentin, Livio Bonello, Lisa Reda, Gianluigi Bödör, Csaba Stavroyianni, Niki Tam, Constantine S. Marasca, Roberto Forconi, Francesco Panayiotidis, Panayiotis Ringshausen, Ingo Jaksic, Ozren Frustaci, Anna Maria Iyengar, Sunil Coscia, Marta Mulligan, Stephen P. Ysebaert, Loïc Strugov, Vladimir Pavlovsky, Carolina Walewska, Renata Österborg, Anders Cortese, Diego Ranghetti, Pamela Baliakas, Panagiotis Stamatopoulos, Kostas Scarfò, Lydia Rosenquist, Richard Ghia, Paolo